Sponsor
Assistance Publique Hopitaux De Marseille
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name Assistance Publique Hopitaux De Marseille appears in 109 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
60 shownImplementation of a Joint Pulmonologist and ENT Consultation in the Care Pathway of Patients Suffering From Asthma and Chronic Rhinosinusitis With Nasal Polyposis: Effectiveness Compared With Consultations by Specialty (CON-PO Study).NCT07134686 · lead sponsor · 2026-07-28
RECRUITINGIntegrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy AgingNCT07202494 · lead sponsor · 2025-05-19
RECRUITINGA Preventive, Multidisciplinary Primary Care Intervention Organized Around a Therapeutic Garden: Acceptability to Patients Suffering from Cardio-neurovascular Pathology and to Those Involved in the Action.NCT06646601 · lead sponsor · 2024-04-09
RECRUITINGProspective Multicenter Cohort Study to Validate Four Groups of Biomarkers for Assessing Lung Cancer Risk Among Patients With Atheromatous Cardiovascular Disease in a Screening PathwayNCT06387017 · lead sponsor · 2024-04-02
RECRUITINGTWEAK, a New Biomarker for Predicting Inflammatory Relapses in Multiple SclerosisNCT03974997 · lead sponsor · 2023-06-16
RECRUITINGMovement Error-processes and Sensorimotor Adaptation in Parkinsonian PatientNCT03371407 · lead sponsor · 2019-07-04
RECRUITINGApplication of ihMT MRI in Multiple SclerosisNCT03600779 · lead sponsor · 2018-06-14
RECRUITINGEpicardial Fat Immunity extRa Cellular vesicleS HearTNCT07817667 · lead sponsor · 2026-10-01
NOT_YET_RECRUITINGEvaluation of the Clinical Contribution of Quantitative MRI in Neuro-imagingNCT07245589 · lead sponsor · 2025-12-01
NOT_YET_RECRUITINGClinical, Radiological, Tissue and Biological Phenotyping for the Analysis of the Transition From Physiology to Pathology in Pulmonary Diseases With Pulmonary HypertensionNCT07184671 · lead sponsor · 2025-09-01
NOT_YET_RECRUITINGProspective Multicenter Cohort Study for the Development and Evaluation of Risk Stratification Tools for Lung Cancers and Their Postoperative Recurrences Using Multimodal Clinical, Radiological, Tissue and Longitudinal Biological Phenotyping Among People at Risk of Lung CancerNCT07042867 · lead sponsor · 2025-07-15
NOT_YET_RECRUITINGIn-depth Characterization of Circulating and Infiltrating Immune Subsets and Tumor Cells in Cancer PatientsNCT06827639 · lead sponsor · 2025-04-30
NOT_YET_RECRUITINGArginin-stimulated Copeptin in Polyuria-polydipsia Syndrome in ChildrenNCT06604975 · lead sponsor · 2025-03-01
NOT_YET_RECRUITINGMonPsy&Moi: A Digital Platform for Collecting Patient-Reported Experience and Outcome Measures in PsychiatryNCT06818227 · lead sponsor · 2025-02-02
NOT_YET_RECRUITINGTrancriptomics and Lipidomics of Epicardial Ectopic FatNCT06590415 · lead sponsor · 2024-10-01
NOT_YET_RECRUITINGEvaluation of the Contribution of a DEMaterialized VIdeo-pedagogical SUpport in the Care Pathway of Lung Cancer Surgery PatientsNCT06577844 · lead sponsor · 2024-07-11
UNKNOWNEarly Biomarkers of Neurodegeneration in Parkinsonian SyndromesNCT06155942 · lead sponsor · 2024-01-15
NOT_YET_RECRUITINGMicrostructural and Sodium 7 Tesla Brain MRI in Idiopathic REM Sleep Behaviour DisorderNCT05976971 · lead sponsor · 2023-10-30
COMPLETEDAssessment of the Efficacy and Tolerance of Sub-cutaneous Re-injection of Autologous Adipose-derived REGEnerative Cells in the Local Treatment of Neuropathic Diabetic Foot ulcERsNCT02866565 · lead sponsor · 2023-06-01
NOT_YET_RECRUITINGPhaRmacOgenetics and Therapeutic Drug Monitoring In SchizophrEniaNCT05839613 · lead sponsor · 2023-05-01
NOT_YET_RECRUITINGStructuring of a Lung Cancer Screening Program Including Clinical, Radiological and Biological Phenotyping Useful for the Development of Individualized Risk Prediction Tools: PREVALUNG ETOILENCT05649046 · lead sponsor · 2023-01-23
UNKNOWNDevelopment of a Proactive Health Care Pathway When Initiating Continuous Subcutaneous Apomorphine Infusion in Patients With Parkinson Disease : Impact on Their Autonomy (AUTAP)NCT05405998 · lead sponsor · 2022-12-01
UNKNOWNBiomarkers of ANTidepressant RESponse and Development Risk of Bipolar DisorderNCT05568823 · lead sponsor · 2022-11-01
UNKNOWNClinical Study of Biomarkers of Stress Resilience: Role of ELK1 and GPR56NCT05488418 · lead sponsor · 2022-09-01
UNKNOWNModulation of Cognitive Control Via Transcranial Continuous Electrical Stimulation of Additional Motor Areas in Parkinson's PatientsNCT04897633 · lead sponsor · 2021-06-02
COMPLETEDExploration by UHF MRI of Hypothalamic Networks Associated to Feeding in Obesity and AnorexiaNCT04451759 · lead sponsor · 2020-06-25
UNKNOWNSarcopenia in Older Patient With Prostate Cancer, Prevalence and Incidence After Androgen Deprivation TherapyNCT04484246 · lead sponsor · 2019-12-11
COMPLETEDFEcal Microbiota TransplantationNCT04001439 · lead sponsor · 2019-12-01
UNKNOWNPulmonary Vascular Impairment in Chronic Obstructive Pulmonary Disease (COPD) Assessed by MRINCT04126616 · lead sponsor · 2019-10-15
COMPLETEDPrecision Immuno-Oncology for Advanced Non-small Cell Lung Cancer Patients With PD-1 ICI ResistanceNCT03833440 · lead sponsor · 2019-10-08
UNKNOWNUse of an Endoluminal-suturing Device for Endoscopic Gastric Reduction as an Aid for Class I Obesity, or Class II Obesity Without ComorbidityNCT03900481 · lead sponsor · 2019-09-17
TERMINATEDRole of the Balano-preputial Furrow 's Microbiota, in Circumcised Patients or Not, in the Acquisition or Transmission of HIVNCT03985137 · lead sponsor · 2019-07-01
UNKNOWNEvaluating the Effectiveness of a New Way of Organizing Primary Health Care to Improve the Management of Alzheimer's DiseaseNCT03360552 · lead sponsor · 2019-01-16
UNKNOWNDoes Chemotherapy Train the Mutation of the Pig-A Gene? (PIGA)NCT03837054 · lead sponsor · 2019-01-10
UNKNOWNMulticenter, Randomized, Comparative and Prospective Study Evaluating the Impact on the Care Path of an Editorial Program Accompanied by Advance Directives in Psychiatry (DAP) for People Suffering From Schizophrenia, Bipolar I Disorder or Schizoaffective DisorderNCT03630822 · lead sponsor · 2019-01-02
COMPLETEDGrey Matter Damage at the Earliest Phase of Multiple Sclerosis : a Longitudinal 7T MRI StudyNCT03659981 · lead sponsor · 2018-12-20
ACTIVE_NOT_RECRUITINGManagement by Individual Cognitive Remediation of Cognitive Disorders of HIV Infected PatientsNCT03639818 · lead sponsor · 2018-12-01
UNKNOWNGerminal Transmission After Endogenization of HIV Sequences Without a Competent Virus for Replication and a Potential Protective RoleNCT03640923 · lead sponsor · 2018-12-01
UNKNOWNEx Vivo Pilot Study of the Impact of Nasal Breathing During the Administration of Inhaled Corticosteroids by Inhalation Chamber in Asthmatic Children Ages Between 1 and 4-year-oldNCT03364959 · lead sponsor · 2018-10-23
TERMINATEDCharacterization of Cortical Injury in Early MS Patients: a 7T MRI StudyNCT03624296 · lead sponsor · 2018-10-01
UNKNOWNAging Stereotypes and Prodromal Alzheimer's DiseaseNCT03138018 · lead sponsor · 2018-07-06
UNKNOWNPhase I Multicenter Trial Combining Nivolumab, Ipilimumab and Hypo-fractionated Radiotherapy for Pretreated Advanced Stage Non-small Cell Lung Cancer PatientsNCT03509584 · lead sponsor · 2018-06-07
TERMINATEDEvolution of the Heart Function When Monitoring Immunotherapies Anti-cancerous Inhibiting PD-1NCT03313544 · lead sponsor · 2018-04-09
UNKNOWNPrecision Immuno-Oncology for Advanced Non-small Cell Lung Cancer Patients With PD-1 ICI Resistance (PIONeeR-BioMarkers (BM) Profiling)NCT03493581 · lead sponsor · 2018-03-08
UNKNOWNProgram for Screening and Prevention of Eating Disorders in Obese Young People in Vulnerable Neighborhoods of Marseille: an Action ResearchNCT03357354 · lead sponsor · 2018-02-01
TERMINATEDAnalysis of Changes in Medication Prescriptions After Hospitalization for 4 Disciplines: Gerontology, Diabetology, Cardiology and Rheumatology: Medical, Pharmaceutical and Economic AspectsNCT03371303 · lead sponsor · 2017-11-01
UNKNOWNRegional Non-comparative Prospective Study of the Impact of Gamma Knife Radiosurgery on Tremor in Multiple SclerosisNCT03339908 · lead sponsor · 2017-10-23
COMPLETEDMRI Study of the Mechanisms Underlying Irreversible Disability in Multiple SclerosisNCT03356366 · lead sponsor · 2017-10-02
ACTIVE_NOT_RECRUITINGImpact of Empaglifozine on Cardiac Ectopic FatNCT03118336 · lead sponsor · 2017-06-16
COMPLETEDVitamin D and Its Metabolites Quantification in Adipose Tissues of Obese and Non-obese Patients.NCT03008525 · lead sponsor · 2017-03-17
UNKNOWNNeeds Assessment of Mediterranean Adolescents With Type 1 Diabetes About Therapeutic Education SessionsNCT02859779 · lead sponsor · 2017-02-04
COMPLETEDDescription of the Evolution of a Cohort of Adolescents With Type 1 Diabetes Following Their Participation in Therapeutic Education Program Based on Social Cognitive Theory: Socio-cognitive Profile, Physiological Behaviour of Therapeutic Adherence and Quality of LifeNCT02859818 · lead sponsor · 2016-12-01
UNKNOWNAnalysis of the Impact of HCV Treatment by Last Generation Direct Antiviral Agents (DAA) on Antiviral Immunity and HIV DNA Reservoir in Coinfected HIV-HCV PatientsNCT03244371 · lead sponsor · 2016-08-31
UNKNOWNRespiratory Disorder During Sleep in the Pregnancy : A Risk Factor in Gestational DiabeteseNCT02756442 · lead sponsor · 2016-04-01
UNKNOWNAssessment of the Mutation of Pig-A Gene as Biomarker of Genotoxic Exposure in HumansNCT02727868 · lead sponsor · 2016-03-03
COMPLETEDClinical Evaluation of the Treatment of Intellectual Metastases by Radiosurgery Gamma Knife by Means of a Support System by Mask.NCT02732769 · lead sponsor · 2016-02-01
COMPLETEDEmotion Endophenotypes in SchizophreniaNCT02834208 · lead sponsor · 2015-12-01
UNKNOWNPsychiatric Disorders and Electrophysiological MarkersNCT02329119 · lead sponsor · 2015-09-01
UNKNOWNMetronomic Chemotherapy Based on Adaptative Bio-mathematical Model of Oral Vinorelbine in Patients With NSCLC or MPMNCT02555007 · lead sponsor · 2015-08-26
COMPLETEDEffects of Various Bariatric Surgical Procedures on Intestinal TRL Metabolism in Obese Type 2 Diabetic PatientsNCT02332434 · lead sponsor · 2015-03-01
UNKNOWNDrugs studied in this sponsor's trials
7 mapped RxNorm conceptsThese drug records are connected through ClinicalTrials.gov studies listing Assistance Publique Hopitaux De Marseille as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.
nivolumab2
dalteparin1
docetaxel1
empagliflozin 10 MG Oral Tablet1
ipilimumab1
metformin1
vinorelbine1
nivolumab RxCUI 1597876 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting
2 trials
dalteparin RxCUI 67109 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
docetaxel RxCUI 72962 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
empagliflozin 10 MG Oral Tablet RxCUI 1545658 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
ipilimumab RxCUI 1094833 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
metformin RxCUI 6809 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
vinorelbine RxCUI 39541 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
Sponsor roles
lead sponsor96
collaborator13
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.